4-Methylmorpholine → 1-(4-chlorophenyl)-N-(3-(4-(2,3-dichlorophenyl)piperazin-1-yl)-2-hydroxy propyl)-2-propyl-1H-imidazole-4-carboxamide

HRID 75487노트

반응식

HRID 75487 반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[CH:12]=[C:11]([C:13]([OH:15])=O)[N:10]=[C:9]2[CH2:16][CH2:17][CH3:18])=[CH:4][CH:3]=1.[Li].Cl.Cl.[NH2:22][CH2:23][CH:24]([OH:40])[CH2:25][N:26]1[CH2:31][CH2:30][N:29]([C:32]2[CH:37]=[CH:36][CH:35]=[C:34]([Cl:38])[C:33]=2[Cl:39])[CH2:28][CH2:27]1.CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.CN1CCOCC1>CN(C=O)C>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([N:8]2[CH:12]=[C:11]([C:13]([NH:22][CH2:23][CH:24]([OH:40])[CH2:25][N:26]3[CH2:27][CH2:28][N:29]([C:32]4[CH:37]=[CH:36][CH:35]=[C:34]([Cl:38])[C:33]=4[Cl:39])[CH2:30][CH2:31]3)=[O:15])[N:10]=[C:9]2[CH2:16][CH2:17][CH3:18])=[CH:6][CH:7]=1

참가 물질

7

실험 절차

To a mixture of lithium 1-(4-chlorophenyl)-2-propyl-1H-imidazole-4-carboxylic acid (compound 6, 150 mg, 0.57 mmol), 1-amino-3-(4-(2,3-dichlorophenyl)piperazin-1-yl)propan-2-ol dihydrochloride (compound 41, 260 mg, 0.68 mmol), EDCI (165 mg, 0.85 mmol) and HOBt (154 mg, 1.14 mmol) in anhydrous DMF (7 mL) was added NMM (190 μl, 1.71 mmol). The reaction mixture was stirred at room temperature for 15 hrs. The mixture was concentrated under reduced pressure. The residue was diluted with CH2Cl2, and washed with water. The organic layer was dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude product was purified by preparative HPLC (purification system, Gilson) to provide the title compound (74 mg, 24%) as a white solid.

후처리

  1. concentrationThe mixture was concentrated under reduced pressure
  2. additionThe residue was diluted with CH2Cl2
  3. washwashed with water
  4. dry with materialThe organic layer was dried over anhydrous MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. customThe crude product was purified by preparative HPLC (purification system, Gilson)

출처 및 근거

ORD 기록
ord-7b12b30d0a9748c9ae17fb83928193a7
출처 데이터셋
uspto-grants-2014_09
특허 번호
US08835436B2

반응 노트

불러오는 중…